Hypothalamic Neurons In Growth Hormone Excess is an important cell type in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
Growth hormone (GH) excess states, primarily from pituitary somatotroph adenomas, have significant hypothalamic involvement through disruption of hypothalamic regulatory neurons. Understanding these hypothalamic interactions is crucial for comprehensive management of acromegaly and gigantism. [1]
GH excess from pituitary adenomas causes: [2]
The hypothalamus plays a critical role in GH regulation through several distinct neuronal populations that are directly affected by pituitary tumors. [3]
Growth hormone-releasing hormone (GHRH) neurons are primarily located in: [4]
These neurons project to the median eminence, where GHRH is released into the hypophyseal portal system to stimulate GH secretion from somatotrophs. [5]
| Effect | Mechanism | Consequences | [6]
|--------|-----------|--------------| [7]
| Compression | Tumor mass effect on median eminence | Reduced GHRH delivery |
| Disruption | Disruption of Arc architecture | Impaired GH pulse generation |
| Dysregulation | Altered hypothalamic signaling | Abnormal GH patterns |
| Stalk effect | Interruption of portal circulation | Loss of hypothalamic control |
Somatostatin (SST) producing neurons are found in:
Somatostatin is released from nerve terminals in the median eminence and acts directly on pituitary somatotrophs to inhibit GH secretion.
In pituitary adenoma patients:
The ghrelin receptor (GHSR) is expressed in hypothalamic neurons:
Large pituitary adenomas can cause:
| Symptom | Hypothalamic Structure Affected | Management |
|---|---|---|
| Visual disturbances | Optic chiasm compression | Surgical decompression |
| Diabetes insipidus | Supraoptic/paraventricular nuclei | Desmopressin replacement |
| Temperature dysregulation | Preoptic area | Supportive care |
| Sleep disturbances | Suprachiasmatic nucleus | Sleep hygiene |
| Autonomic dysfunction | Autonomic centers | Monitoring |
Hypothalamic involvement leads to:
| Treatment | Hypothalamic Effects |
|---|---|
| Surgery | Relief of compression, potential injury |
| Somatostatin analogs | May affect hypothalamic SST tone |
| GH receptor antagonists | Do not affect hypothalamic function |
| Radiation | Potential late hypothalamic damage |
The hypothalamic-pituitary-GH-IGF-1 axis involves:
Hypothalamic neurons integrate metabolic signals:
Somatostatin analogs (first-line medical therapy):
Transsphenoidal surgery:
The arcuate nucleus contains multiple populations:
Dopamine from hypothalamic nuclei:
The study of Hypothalamic Neurons In Growth Hormone Excess has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
Katznelson et al. Acromegaly Guidelines (2021). 2021. ↩︎
Giustina et al. Acromegaly Consensus (2020). 2020. ↩︎
Müller et al. Hypothalamic GHRH Neurons (2019). 2019. ↩︎
Kineman et al. Somatostatin and GH Regulation (2018). 2018. ↩︎
Cordoba-Chacon et al. Ghrelin and GH Axis (2021). 2021. ↩︎